liver neoplasms

Prognostic model for unresectable hepatocellular carcinoma treated with dual PD-1 and angiogenesis blockade therapy
Zhiqiang Mo, Ling Lv, Qicong Mai, Qiao Li, Jian He, Tao Zhang, Jingwu Xu, Jiayan Fang, Ning Shi, Qing Gou, Xiaoming Chen, Jing Zhang, Wenhang Zhuang, Haosheng Jin

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008191; DOI: 10.1136/jitc-2023-008191
Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression
Tingting Lv, Xiaofeng Xiong, Wei Yan, Mei Liu, Hongwei Xu, Qin He

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004763; DOI: 10.1136/jitc-2022-004763
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Brett Marinelli, Edward Kim, Antonio D'Alessio, Mario Cedillo, Ishan Sinha, Neha Debnath, Masatoshi Kudo, Naoshi Nishida, Anwaar Saeed, Hannah Hildebrand, Ahmed O Kaseb, Yehia I Abugabal, Anjana Pillai, Yi-Hsiang Huang, Uqba Khan, Mahvish Muzaffar, Abdul Rafeh Naqash, Rahul Patel, Aaron Fischman, Vivian Bishay, Dominik Bettinger, Max Sung, Celina Ang, Myron Schwartz, David J Pinato, Thomas Marron

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004205; DOI: 10.1136/jitc-2021-004205
Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor–treated unresectable hepatocellular carcinoma
Pei-Chang Lee, Chi-Jung Wu, Ya-Wen Hung, Chieh Ju Lee, Chen-Ta Chi, I-Cheng Lee, Kuo Yu-Lun, Shih-Hsuan Chou, Jiing-Chyuan Luo, Ming-Chih Hou, Yi-Hsiang Huang

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004779; DOI: 10.1136/jitc-2022-004779
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancer
Jia-Yi Deng, Qing Gou, Lingling Yang, Zhi-Hong Chen, Ming-Yi Yang, Xiao-Rong Yang, Hong-Hong Yan, Xue-Wu Wei, Jia-Qi Liu, Jian Su, Wen-Zhao Zhong, Chong-Rui Xu, Yi-Long Wu, Qing Zhou

Journal for ImmunoTherapy of Cancer Jul 2023, 11 (7) e007218; DOI: 10.1136/jitc-2023-007218
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial
Kelley Coffman-D'Annibale, Yuta Myojin, Cecilia Monge, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008079; DOI: 10.1136/jitc-2023-008079
Dominant neoantigen verification in hepatocellular carcinoma by a single-plasmid system coexpressing patient HLA and antigen
Pu Chen, Dongbo Chen, Dechao Bu, Jie Gao, Wanying Qin, Kangjian Deng, Liying Ren, Shaoping She, Wentao Xu, Yao Yang, Xingwang Xie, Weijia Liao, Hongsong Chen

Journal for ImmunoTherapy of Cancer Apr 2023, 11 (4) e006334; DOI: 10.1136/jitc-2022-006334
Response to 'Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC' by Yang et al
Kun Li, Yunfei Qin, Linsen Ye

Journal for ImmunoTherapy of Cancer Mar 2023, 11 (3) e006648; DOI: 10.1136/jitc-2022-006648
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Tim F Greten, Ghassan K Abou-Alfa, Ann-Lii Cheng, Austin G Duffy, Anthony B. El-Khoueiry, Richard S Finn, Peter R Galle, Lipika Goyal, Aiwu Ruth He, Ahmed O Kaseb, Robin Kate Kelley, Riccardo Lencioni, Amaia Lujambio, Donna Mabry Hrones, David J Pinato, Bruno Sangro, Roberto I Troisi, Andrea Wilson Woods, Thomas Yau, Andrew X Zhu, Ignacio Melero

Journal for ImmunoTherapy of Cancer Sep 2021, 9 (9) e002794; DOI: 10.1136/jitc-2021-002794
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
Jiongjie Yu, Sunbin Ling, Jiachen Hong, Lincheng Zhang, Wei Zhou, Lu Yin, Shengjun Xu, Qingyang Que, Yongfeng Wu, Qifan Zhan, Jiaqi Bao, Nan Xu, Yuchen Liu, Kangchen Chen, Xuyong Wei, Zhikun Liu, Tingting Feng, Lin Zhou, Haiyang Xie, Shuai Wang, Jimin Liu, Shusen Zheng, Xiao Xu

Journal for ImmunoTherapy of Cancer Nov 2023, 11 (11) e007479; DOI: 10.1136/jitc-2023-007479

Main menu

liver neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

liver neoplasms

Pages